Global Protein Drugs Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Antibody Drugs
  • 1.2.3 Peptide Hormones
  • 1.2.4 Blood Products
  • 1.2.5 Enzymes
• 1.3 Market by Application
  • 1.3.1 Global Protein Drugs Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Protein Drugs Market Perspective (2016-2027)
• 2.2 Protein Drugs Growth Trends by Regions
  • 2.2.1 Protein Drugs Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Protein Drugs Historic Market Share by Regions (2016-2021)
  • 2.2.3 Protein Drugs Forecasted Market Size by Regions (2022-2027)
• 2.3 Protein Drugs Industry Dynamic
  • 2.3.1 Protein Drugs Market Trends
  • 2.3.2 Protein Drugs Market Drivers
  • 2.3.3 Protein Drugs Market Challenges
  • 2.3.4 Protein Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Protein Drugs Players by Revenue
  • 3.1.1 Global Top Protein Drugs Players by Revenue (2016-2021)
  • 3.1.2 Global Protein Drugs Revenue Market Share by Players (2016-2021)
• 3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Protein Drugs Revenue
• 3.4 Global Protein Drugs Market Concentration Ratio
  • 3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2020
• 3.5 Protein Drugs Key Players Head office and Area Served
• 3.6 Key Players Protein Drugs Product Solution and Service
• 3.7 Date of Enter into Protein Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Protein Drugs Breakdown Data by Type

• 4.1 Global Protein Drugs Historic Market Size by Type (2016-2021)
• 4.2 Global Protein Drugs Forecasted Market Size by Type (2022-2027)

5 Protein Drugs Breakdown Data by Application

• 5.1 Global Protein Drugs Historic Market Size by Application (2016-2021)
• 5.2 Global Protein Drugs Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Protein Drugs Market Size (2016-2027)
• 6.2 North America Protein Drugs Market Size by Type
  • 6.2.1 North America Protein Drugs Market Size by Type (2016-2021)
  • 6.2.2 North America Protein Drugs Market Size by Type (2022-2027)
  • 6.2.3 North America Protein Drugs Market Size by Type (2016-2027)
• 6.3 North America Protein Drugs Market Size by Application
  • 6.3.1 North America Protein Drugs Market Size by Application (2016-2021)
  • 6.3.2 North America Protein Drugs Market Size by Application (2022-2027)
  • 6.3.3 North America Protein Drugs Market Size by Application (2016-2027)
• 6.4 North America Protein Drugs Market Size by Country
  • 6.4.1 North America Protein Drugs Market Size by Country (2016-2021)
  • 6.4.2 North America Protein Drugs Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Protein Drugs Market Size (2016-2027)
• 7.2 Europe Protein Drugs Market Size by Type
  • 7.2.1 Europe Protein Drugs Market Size by Type (2016-2021)
  • 7.2.2 Europe Protein Drugs Market Size by Type (2022-2027)
  • 7.2.3 Europe Protein Drugs Market Size by Type (2016-2027)
• 7.3 Europe Protein Drugs Market Size by Application
  • 7.3.1 Europe Protein Drugs Market Size by Application (2016-2021)
  • 7.3.2 Europe Protein Drugs Market Size by Application (2022-2027)
  • 7.3.3 Europe Protein Drugs Market Size by Application (2016-2027)
• 7.4 Europe Protein Drugs Market Size by Country
  • 7.4.1 Europe Protein Drugs Market Size by Country (2016-2021)
  • 7.4.2 Europe Protein Drugs Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Protein Drugs Market Size (2016-2027)
• 8.2 Asia-Pacific Protein Drugs Market Size by Type
  • 8.2.1 Asia-Pacific Protein Drugs Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Protein Drugs Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Protein Drugs Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Protein Drugs Market Size by Application
  • 8.3.1 Asia-Pacific Protein Drugs Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Protein Drugs Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Protein Drugs Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Protein Drugs Market Size by Region
  • 8.4.1 Asia-Pacific Protein Drugs Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Protein Drugs Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Protein Drugs Market Size (2016-2027)
• 9.2 Latin America Protein Drugs Market Size by Type
  • 9.2.1 Latin America Protein Drugs Market Size by Type (2016-2021)
  • 9.2.2 Latin America Protein Drugs Market Size by Type (2022-2027)
  • 9.2.3 Latin America Protein Drugs Market Size by Type (2016-2027)
• 9.3 Latin America Protein Drugs Market Size by Application
  • 9.3.1 Latin America Protein Drugs Market Size by Application (2016-2021)
  • 9.3.2 Latin America Protein Drugs Market Size by Application (2022-2027)
  • 9.3.3 Latin America Protein Drugs Market Size by Application (2016-2027)
• 9.4 Latin America Protein Drugs Market Size by Country
  • 9.4.1 Latin America Protein Drugs Market Size by Country (2016-2021)
  • 9.4.2 Latin America Protein Drugs Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Protein Drugs Market Size (2016-2027)
• 10.2 Middle East & Africa Protein Drugs Market Size by Type
  • 10.2.1 Middle East & Africa Protein Drugs Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Protein Drugs Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Protein Drugs Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Protein Drugs Market Size by Application
  • 10.3.1 Middle East & Africa Protein Drugs Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Protein Drugs Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Protein Drugs Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Protein Drugs Market Size by Country
  • 10.4.1 Middle East & Africa Protein Drugs Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Protein Drugs Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Eli Lilly
  • 11.1.1 Eli Lilly Company Details
  • 11.1.2 Eli Lilly Business Overview
  • 11.1.3 Eli Lilly Protein Drugs Introduction
  • 11.1.4 Eli Lilly Revenue in Protein Drugs Business (2016-2021)
  • 11.1.5 Eli Lilly Recent Development
• 11.2 Abbott Laboratories
  • 11.2.1 Abbott Laboratories Company Details
  • 11.2.2 Abbott Laboratories Business Overview
  • 11.2.3 Abbott Laboratories Protein Drugs Introduction
  • 11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2016-2021)
  • 11.2.5 Abbott Laboratories Recent Development
• 11.3 UCB Group
  • 11.3.1 UCB Group Company Details
  • 11.3.2 UCB Group Business Overview
  • 11.3.3 UCB Group Protein Drugs Introduction
  • 11.3.4 UCB Group Revenue in Protein Drugs Business (2016-2021)
  • 11.3.5 UCB Group Recent Development
• 11.4 Schering-Plough Corporation
  • 11.4.1 Schering-Plough Corporation Company Details
  • 11.4.2 Schering-Plough Corporation Business Overview
  • 11.4.3 Schering-Plough Corporation Protein Drugs Introduction
  • 11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2016-2021)
  • 11.4.5 Schering-Plough Corporation Recent Development
• 11.5 Genentech
  • 11.5.1 Genentech Company Details
  • 11.5.2 Genentech Business Overview
  • 11.5.3 Genentech Protein Drugs Introduction
  • 11.5.4 Genentech Revenue in Protein Drugs Business (2016-2021)
  • 11.5.5 Genentech Recent Development
• 11.6 Johnson＆Johnson
  • 11.6.1 Johnson＆Johnson Company Details
  • 11.6.2 Johnson＆Johnson Business Overview
  • 11.6.3 Johnson＆Johnson Protein Drugs Introduction
  • 11.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2016-2021)
  • 11.6.5 Johnson＆Johnson Recent Development
• 11.7 Bristol-Myers Squibb
  • 11.7.1 Bristol-Myers Squibb Company Details
  • 11.7.2 Bristol-Myers Squibb Business Overview
  • 11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
  • 11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2016-2021)
  • 11.7.5 Bristol-Myers Squibb Recent Development
• 11.8 Novo Nordisk
  • 11.8.1 Novo Nordisk Company Details
  • 11.8.2 Novo Nordisk Business Overview
  • 11.8.3 Novo Nordisk Protein Drugs Introduction
  • 11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2016-2021)
  • 11.8.5 Novo Nordisk Recent Development
• 11.9 Biogen Idec
  • 11.9.1 Biogen Idec Company Details
  • 11.9.2 Biogen Idec Business Overview
  • 11.9.3 Biogen Idec Protein Drugs Introduction
  • 11.9.4 Biogen Idec Revenue in Protein Drugs Business (2016-2021)
  • 11.9.5 Biogen Idec Recent Development
• 11.10 Dendreon Corporation
  • 11.10.1 Dendreon Corporation Company Details
  • 11.10.2 Dendreon Corporation Business Overview
  • 11.10.3 Dendreon Corporation Protein Drugs Introduction
  • 11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2016-2021)
  • 11.10.5 Dendreon Corporation Recent Development
• 11.11 Amgen Inc.
  • 11.11.1 Amgen Inc. Company Details
  • 11.11.2 Amgen Inc. Business Overview
  • 11.11.3 Amgen Inc. Protein Drugs Introduction
  • 11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2016-2021)
  • 11.11.5 Amgen Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer